Citation Impact
Citing Papers
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Effects of Tamoxifen and Melatonin on Mammary Gland Cancer Induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, Respectively, in Female Sprague-Dawley Rats
2001
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
The frequency and the role ofChlamydia trachomatisinfection in premature labor
1998
Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters
2002
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Tamoxifen‐loaded thiolated alginate‐albumin nanoparticles as antitumoral drug delivery systems
2012
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy
1996
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice
2006 StandoutNobel
Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments?
2001
Diagnosis and Management of Endometrial Polyps: A Critical Review of the Literature
2011
Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes
2008 Standout
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
Endometrial assessment re‐visited
1999
Systematic reviews of evaluations of diagnostic and screening tests
2001 Standout
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Molecular detection of micro-metastasis in breast cancer
2002
Does tamoxifen cause cancer in humans?
1998
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
1994
Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities
1998
Ovarian Follicle Atresia: A Hormonally Controlled Apoptotic Process*
1994
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women
1999
Flavonoids: Promising anticancer agents
2003 Standout
Ovarian Carcinoma in an Adolescent With Transgenerational Exposure to Diethylstilbestrol
2003
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Coffee and Health: A Review of Recent Human Research
2006 Standout
Uterine adenomyosis: a need for uniform terminology and consensus classification
2008
Environmental epigenomics and disease susceptibility
2007 Standout
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer
2000
FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age
2011 Standout
Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG‐1 ovarian cancer cells
2003
ESHRE guideline: recurrent pregnancy loss
2018 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Chemistry and biology of the polyene macrolide antibiotics.
1973
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Numerical Classification of Streptomyces and Related Genera
1983 Standout
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Mechanisms of Estrogen Action
2001 Standout
Life cycle of connexins in health and disease
2006 Standout
Surgical approach to hysterectomy for benign gynaecological disease
2015 Standout
STREPTOMYCES COELICOLOR MÜLLER AND STREPTOMYCES VIOLACEORUBER WAKSMAN AND CURTIS, TWO DISTINCTLY DIFFERENT ORGANISMS
1959
Selective Estrogen Receptor Modulators: Clinical Spectrum*
1999
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 StandoutScience
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Perspectives on medicinal properties of plumbagin and its analogs
2010 Standout
Works of Ilan Cohen being referenced
Serum-Specific Antibodies forChlamydiatrachomatisin Preterm Premature Rupture of the Membranes
1990
Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients
1999
Estrogen Replacement in Postmenopausal Women: Are We Currently Overdosing Our Patients?
1994
Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer Patients
1994
Malignant Endometrial Polyps in Postmenopausal Breast Cancer Tamoxifen-Treated Patients
1999
Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer
1993
Role of Prolonged Stimulation of Tamoxifen Therapy in the Etiology of Endometrial Sarcomas
1993
Long-Term Transvaginal Ultrasonographic Endometrial Follow-up in Postmenopausal Breast Cancer Patients with Tamoxifen Treatment
1999
Simple Ovarian Cysts in Postmenopausal Patients with Breast Carcinoma Treated with Tamoxifen: Long-term Follow-up
2003
Detection of Micrometastasis by Cytokeratin-20 (Reverse Transcription Polymerase Chain Reaction) in Lymph Nodes of Patients with Endometrial Cancer
2000
Endometrial pathologies associated with postmenopausal tamoxifen treatment
2004
Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer
1994
Premature Ovarian Failure
1991
Ascosin, an antifugal antibiotic produced by a streptomycete.
1952
Adenomyosis in Postmenopausal Breast Cancer Patients Treated with Tamoxifen: A New Entity?
1995
Ovarian cancer in women given diethylstilboestrol in pregnancy: Two case reports
1987